- Robot assisted percutaneous coronary intervention (PCI) systems are advanced medical technologies that enhance precision and control during coronary procedures by enabling interventional cardiologists to perform surgeries with robotic assistance
- The growth of this market is significantly driven by the rising prevalence of cardiovascular diseases, increasing demand for minimally invasive interventions, and continuous technological advancements in robotic-assisted platforms
- North America is expected to dominate the robot assisted percutaneous coronary intervention (PCI) market with a market share of 40.4%, due to robust healthcare infrastructure, early adoption of advanced robotic technologies, and a high burden of cardiovascular diseases
- Asia-Pacific is expected to be the fastest growing region in the robot assisted percutaneous coronary intervention (PCI) market with a market share of 17.8%, due to the rising incidence of coronary artery disease, improving healthcare infrastructure, and growing demand for advanced surgical technologies
- Robot-assisted procedures segment is expected to dominate the market with a market share of 62.5% due to its superior precision, enhanced control during complex procedures, reduced risk of operator fatigue, and lower radiation exposure
